- About Us
- Procurement
- Corporate Compliance
- Calendar
- Contact Us
Wednesday, March 04, 2026
Financial News Conference on Fiscal 2025
Bayer delivers upgraded 2025 ambition, projects solid 2026, focused on strategic priorities
- Group sales at 45.575 billion euros (Fx & p adj. plus 1.1 percent), negative currency effects of 1.742 billion euros
- EBITDA before special items at 9.669 billion euros (minus 4.5 percent)
- Core earnings per share at 4.91 euros (minus 2.8 percent)
- Net income at minus 3.620 billion euros – high special charges for litigations
- Free cash flow declines to 2.084 billion euros, net financial debt reduced to 29.843 billion euros
- Proposed dividend of 0.11 euros per share
- Earnings figures and outlook reflect class settlement agreement to resolve current and future Roundup™ (glyphosate) claims
- Outlook for 2026: Stable sales and earnings (Fx adj.), free cash flow to be heavily impacted by settlement payments
- Advancing innovation opportunities across divisions to drive mid-term growth
Strategy and Financial Update
Bayer CEO Bill Anderson provides an update on the fiscal 2025 and gives an outlook for 2026 - in 90 seconds!